Viking Global Investors LP Roivant Sciences Ltd. Call Options Transaction History
Viking Global Investors LP
- $31.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
363Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$844 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$629 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$554 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$498 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$414 Million32.33% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $9.92B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...